HMG CoA reductase inhibitors reduce ischemic brain injury of Wistar rats through decreasing oxidative stress on neurons

被引:65
作者
Hayashi, T [1 ]
Hamakawa, K [1 ]
Nagotani, S [1 ]
Jin, G [1 ]
Li, F [1 ]
Deguchi, K [1 ]
Sehara, Y [1 ]
Zhang, H [1 ]
Nagano, I [1 ]
Shoji, M [1 ]
Abe, K [1 ]
机构
[1] Okayama Univ, Grad Sch Med & Dent, Dept Neurol, Okayama 7008558, Japan
关键词
cell death; oxidative stress; rat; statin;
D O I
10.1016/j.brainres.2004.12.051
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Statins possess neuroprotective effect against ischemic damage, but how they protect neurons is not exactly made clear. We speculated that anti-oxidative property of statins is implicated, and investigated statins' influences on the oxidative neuronal damage in the brain after ischemia. After 14 days of atorvastatin, pitavastatin, simvastatin, or vehicle administration, 90 min of middle cerebral artery occlusion was imposed on Wistar rats. The production of 4-hydroxynonenal (HNE) and 8-hydroxy-2-deoxyguanosine (8-OHdG), both of which are oxidative stress markers, as well as infarction formation were investigated at 1 day after the reperfusion. In the vehicle group, massive infarction was confirmed and FINE and 8-OHdG are robustly produced. In the statins-treated group, the infarction was smaller and the HNE and 8-OHdG production was less prominent than the vehicle group. Among the statins investigated, simvastatin was most effective for reducing oxidative stress and infarction volume, which may be brought by its highly lipophilic property. Reduction of oxidative stress by statins may be one main reason in ameliorating ischemic brain damage in rats. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:52 / 58
页数:7
相关论文
共 37 条
[1]   Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction [J].
Amarenco, P .
NEUROLOGY, 2001, 57 (05) :S35-S44
[2]   The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation [J].
Belinky, PA ;
Aviram, M ;
Fuhrman, B ;
Rosenblat, M ;
Vaya, J .
ATHEROSCLEROSIS, 1998, 137 (01) :49-61
[3]   CONCENTRATIONS OF PRAVASTATIN AND LOVASTATIN IN CEREBROSPINAL-FLUID IN HEALTHY-SUBJECTS [J].
BOTTI, RE ;
TRISCARI, J ;
PAN, HY ;
ZAYAT, J .
CLINICAL NEUROPHARMACOLOGY, 1991, 14 (03) :256-261
[4]   A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
SCIENCE, 1986, 232 (4746) :34-47
[5]   Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors [J].
Bruce, AJ ;
Boling, W ;
Kindy, MS ;
Peschon, J ;
Kraemer, PJ ;
Carpenter, MK ;
Holtsberg, FW ;
Mattson, MP .
NATURE MEDICINE, 1996, 2 (07) :788-794
[6]   Role of oxidants in ischemic brain damage [J].
Chan, PH .
STROKE, 1996, 27 (06) :1124-1129
[7]   Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine [J].
Chen, LY ;
Haught, WH ;
Yang, BC ;
Saldeen, TGP ;
Parathasarathy, S ;
Mehta, JL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (02) :569-575
[8]   Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase [J].
Endres, M ;
Laufs, U ;
Huang, ZH ;
Nakamura, T ;
Huang, P ;
Moskowitz, MA ;
Liao, JK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) :8880-8885
[9]   Aggressive lipid therapy in the statin era [J].
Farmer, JA .
PROGRESS IN CARDIOVASCULAR DISEASES, 1998, 41 (02) :71-94
[10]   A comparative study of the in vitro antioxidant activity of statins [J].
Franzoni, F ;
Quiñones-Galvan, A ;
Regoli, F ;
Ferrannini, E ;
Galetta, F .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2003, 90 (2-3) :317-321